SIRT1 and breast cancer: However, our quantitative analysis found that Sirt1 overexpression was not associated with patient survival in breast cancer, colorectal cancer, and gastric cancer, which was inconsistent with a majority of previous findings, and this contradiction could result from the data collection process.